These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 22674493

  • 21. Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: results of a randomized controlled crossover study.
    Vecchioli-Scaldazza C, Morosetti C, Berouz A, Giannubilo W, Ferrara V.
    Gynecol Obstet Invest; 2013; 75(4):230-4. PubMed ID: 23548260
    [Abstract] [Full Text] [Related]

  • 22. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG, Bachmann G, Scarpero H, Jumadilova Z, Sun F, Morrow JD, Guan Z, Bavendam T.
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [Abstract] [Full Text] [Related]

  • 23. Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data.
    Vandoninck V, van Balken MR, Finazzi Agrò E, Petta F, Micali F, Heesakkers JP, Debruyne FM, Kiemeney LA, Bemelmans BL.
    Neurourol Urodyn; 2003 Sep; 22(3):227-32. PubMed ID: 12707873
    [Abstract] [Full Text] [Related]

  • 24. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder.
    Noblett K, Siegel S, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Kan F, Berg KC.
    Neurourol Urodyn; 2016 Feb; 35(2):246-51. PubMed ID: 25546568
    [Abstract] [Full Text] [Related]

  • 25. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder.
    Salatzki J, Liechti MD, Spanudakis E, Gonzales G, Baldwin J, Haslam C, Pakzad M, Panicker JN.
    BJU Int; 2019 May; 123(5A):E20-E28. PubMed ID: 30552801
    [Abstract] [Full Text] [Related]

  • 26. Percutaneous Tibial Nerve Stimulation Improves Female Sexual Function in Women With Overactive Bladder Syndrome.
    Musco S, Serati M, Lombardi G, Lumi E, Parisi AI, Del Popolo G, Finazzi Agrò E.
    J Sex Med; 2016 Feb; 13(2):238-42. PubMed ID: 26803455
    [Abstract] [Full Text] [Related]

  • 27. Intravesical electrical stimulation treatment for overactive bladder: An observational study.
    Yune JJ, Shen JK, Pierce MA, Hardesty JS, Kim J, Siddighi S.
    Investig Clin Urol; 2018 Jul; 59(4):246-251. PubMed ID: 29984339
    [Abstract] [Full Text] [Related]

  • 28. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
    Garely AD, Lucente V, Vapnek J, Smith N.
    Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Percutaneous tibial nerve stimulation for treatment of overactive bladder and urinary retention in an elderly population.
    Zinkgraf K, Quinn AO, Ketterhagen D, Kreuziger B, Stevenson K.
    Urol Nurs; 2009 Mar; 29(1):30-4. PubMed ID: 19331273
    [Abstract] [Full Text] [Related]

  • 31. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
    Kubota Y, Kojima Y, Shibata Y, Imura M, Kohri K, Sasaki S.
    Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study.
    Chancellor MB, Zinner N, Whitmore K, Kobashi K, Snyder JA, Siami P, Karram M, Laramée C, Capo' JP, Seifeldin R, Forero-Schwanhaeuser S, Nandy I.
    Clin Ther; 2008 Oct; 30(10):1766-81. PubMed ID: 19014833
    [Abstract] [Full Text] [Related]

  • 33. Outcome of percutaneous tibial nerve stimulation (PTNS) for fecal incontinence: a prospective cohort study.
    Hotouras A, Murphy J, Walsh U, Allison M, Curry A, Williams NS, Knowles C, Chan CL.
    Ann Surg; 2014 May; 259(5):939-43. PubMed ID: 23979291
    [Abstract] [Full Text] [Related]

  • 34. Does patient age impact outcomes of neuromodulation?
    Peters KM, Killinger KA, Gilleran J, Boura JA.
    Neurourol Urodyn; 2013 Jan; 32(1):30-6. PubMed ID: 22674536
    [Abstract] [Full Text] [Related]

  • 35. Subjective and objective responses to PTNS and predictors for success: a retrospective cohort study of percutaneous tibial nerve stimulation for overactive bladder.
    Iyer S, Laus K, Rugino A, Botros C, Lozo S, Botros SM, Goldberg R, Tomezsko J, Gafni-Kane A, Wroblewski K, Sand P.
    Int Urogynecol J; 2019 Aug; 30(8):1253-1259. PubMed ID: 30467763
    [Abstract] [Full Text] [Related]

  • 36. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA, Roehrborn CG, Gong J, Sun F, Guan Z.
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [Abstract] [Full Text] [Related]

  • 37. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
    Kabay S, Canbaz Kabay S, Cetiner M, Mestan E, Sevim M, Ayas S, Ozden H, Ozisik Karaman H.
    Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213
    [Abstract] [Full Text] [Related]

  • 38. Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study.
    de Sèze M, Raibaut P, Gallien P, Even-Schneider A, Denys P, Bonniaud V, Gamé X, Amarenco G.
    Neurourol Urodyn; 2011 Mar; 30(3):306-11. PubMed ID: 21305588
    [Abstract] [Full Text] [Related]

  • 39. Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation.
    Siegel S, Noblett K, Mangel J, Bennett J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Zylstra S, Kan F, Berg KC.
    J Urol; 2018 Jan; 199(1):229-236. PubMed ID: 28709886
    [Abstract] [Full Text] [Related]

  • 40. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome.
    Ramírez-García I, Kauffmann S, Blanco-Ratto L, Carralero-Martínez A, Sánchez E.
    Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.